norm: anixa biosciencesNAICS Pharmaceutical Preparations · USno LEI · CIK 0000715446Max severity: Low

Canonical registry

Anixa Biosciences Inc

ent_019fa1f5136e00874eb5681813509776

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Anixa Biosciences Inc
Normalized: anixa biosciences— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0000715446
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-01-16
Item 1C cybersecurity disclosure deferred: the registrant states the required Item 106 of Regulation S-K disclosure will be provided in its annual report for the fiscal year ended October 31, 2024, which is the first annual report for a fiscal year ending on or after December 15, 2023. No cybersecurity incident is described in this filing.